Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 41,176 | 0 | 0 | 0 | 0 |
| Gross Profit | 41,176 | N/A | N/A | N/A | N/A |
| Operating Expenses | 39,329 | 75,865 | 51,730 | 41,170 | 30,191 |
| Operating Income | 1,847 | -75,865 | -51,730 | -41,170 | -30,191 |
| Interest Expense | 0 | 0 | 110 | 614 | 1,030 |
| Other Income | 94 | 1,428 | 1,669 | 885 | 175 |
| Pre-tax Income | 1,941 | -74,438 | -50,171 | -40,900 | -31,045 |
| Income Tax | N/A | -2,254 | N/A | -9,376 | N/A |
| Net Income Continuous | 1,941 | -72,184 | -50,171 | -31,523 | -31,045 |
| Net Income | $1,941 | $-72,184 | $-50,171 | $-31,523 | $-31,045 |
| EPS Basic Total Ops | 0.40 | -14.80 | -10.32 | -6.64 | -7.92 |
| EPS Basic Continuous Ops | 0.38 | -14.80 | -10.35 | -6.65 | -7.88 |
| EPS Diluted Total Ops | 0.40 | -14.80 | -10.32 | -6.64 | -7.92 |
| EPS Diluted Continuous Ops | 0.38 | -14.80 | -10.35 | -6.65 | -7.88 |
| EPS Diluted Before Non-Recurring Items | 0.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,936 | $-76,468 | $-51,794 | $-41,138 | $-29,724 |